Published in Hepatitis Weekly, June 20th, 2005
Study 1: A scientist reviews the treatment of hepatocellular carcinoma in a recent issue of Best Practice and Research in Clinical Gastroenterology.
According to a study from Germany, "Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well defined and some of the multiple steps involved in hepatocarcinogeresis have been elucidated in recent years. Despite these scientific advances and the implementation of measures for early HCC detection in patients at risk, patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly